U.S., March 5 -- ClinicalTrials.gov registry received information related to the study (NCT06857045) titled 'Comparison Three vs Six Months of Dual Anti-platelet Therapy After Sirolimus-eluting Stent Implantation' on Feb. 26.
Brief Summary: This study is a prospective, multicenter, open-label, randomized controlled clinical trial, aims to assess the clinical non-inferiority of 3 months (short-term) vs 6 months (long-term) of Dual Anti-Platelet Therapy (DAPT) in patients after implanted NOVA intracranial sirolimus-eluting stent system. All participants met the inclusion criteria will be 1:1 randomized to 3 months or 12 months of DAPT at index procedure.
Study Start Date: July 09, 2024
Study Type: INTERVENTIONAL
Condition:
Intracranial A...